We are pleased to share Wellnex Life (ASX: WNX), owner and developer of some of Australia's leading health brands, has recently released a key ASX announcement.
Wellnex Life Limited (ASX: WNX) (“Wellnex” or “the Company”) is pleased to provide the following operational update along with its Appendix 4C for the quarter ended 31 March 2025 (“Q3 FY25”).
Announcement Highlights
- Quarterly cash receipts of $6.6 million, an increase of 69% compared to the previous quarter (Q2 FY25: $3.9 million)
- Positive net cash flow from operations $0.04 million compared to negative cash flow result in the previous quarter (Q2 FY25: -$0.80 million)
- Sales for Q3 FY25 of $5.3 million, an increase of 35% compared to the prior comparative period PCP (Q3 FY24: $3.9 million), with the increase largely driven by: o Sales from Wellnex Life’s brands up 41% to $4.1 million compared to PCP (Q3 FY24: $3.0 million) o Sales from IP licensing up 36% to $1.3 million compared to PCP (Q3 FY24: $0.95 million)
- Completion and admission to the AIM market of the London Stock Exchange (“AIM”). The London Stock Exchange is home to the some of the world’s largest consumer healthcare companies
- Payment of the deferred consideration for the acquisition of Pain Away, which will save the Company $0.6 million in annual costs
- Extinguishment of the convertible notes post completion of the quarter, which will save the Company $0.85 million in annual interest costs
London Stock Exchange (LSE):
Wellnex Life was admitted to AIM on 21 March 2025. The LSE is home to some of the world’s largest consumer healthcare companies in the world. This has enabled the Company to fully satisfy the deferred consideration for the acquisition of Pain Away and post close of the quarter redeem the balance of the convertible notes. This is a transformational moment for the Company, with the strengthening of the balance sheet leading to savings of $1.4 million in annual costs. The AIM listing is also expected to accelerate the Company’s international expansion with its innovative brands and products.
Congratulations to George Karafotias, Zack Bozinovski, the board and the team at Wellnex Life for reaching this significant milestone.
Read the full Wellnex Life ASX announcement here.
To learn more about Wellnex Life and stay up to date with investor information, subscribe to the Company's Chairman’s List.
